What does Vaxil Bio Ltd. do?

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.

What is Vaxil Bio Ltd.'s P/E and P/B ratio?

Vaxil Bio Ltd. has a P/E ratio of 0.9 and a P/B ratio of 0.43.

What is Vaxil Bio Ltd.'s debt-to-equity ratio?

Vaxil Bio Ltd. has a debt-to-equity ratio of 0.00.

Does Vaxil Bio Ltd. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Vaxil Bio Ltd..

Where can I read the latest news about Vaxil Bio Ltd.?

Recent headlines about Vaxil Bio Ltd. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Vaxil Bio Ltd. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Vaxil Bio Ltd.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

PositoAI

a positivity index

Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights

Vaxil Bio Ltd.

Q: What is Vaxil Bio Ltd.'s Positivity rank?

Vaxil Bio Ltd. is ranked #707 of 12,632 companies globally and #45 of 1,768 in Canada on PositoAI, with a Positivity Score of 24,515.

TSXV: VXL · Healthcare

Positivity Index

#707 / 12,632

Global

#45 / 1,768

Canada

Positivity Score

24,515

Rank→

PosiRed: no active red flags

Vaxil Bio Ltd. — Overview & Financial Snapshot

Vaxil Bio Ltd. (TSXV: VXL) is a Healthcare company, ranked #707 of 12,632 companies globally and #45 of 1,768 in Canada on PositoAI, with a Positivity Score of 24,515. Its market capitalisation is ₹3.52 Cr (C$517,922), P/E ratio is 0.9 and P/B ratio is 0.43. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Powered by OpenAI

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.